PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 1981Heart98 citationsOpen Access

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

WMWilliam J. McKennaLHLouise HarrisGPGracia Herranz Perez

Key Points

  • To compare the antiarrhythmic efficacy of amiodarone versus verapamil in managing refractory arrhythmias associated with hypertrophic cardiomyopathy.
  • Assessed antiarrhythmic outcomes of amiodarone and verapamil in N=19 patients with hypertrophic cardiomyopathy complicated by refractory arrhythmias.

Structured PICO

Does amiodarone reduce the incidence of arrhythmia compared to verapamil in patients with hypertrophic cardiomyopathy complicated by refractory arrhythmias?

P
Population
19 patients with hypertrophic cardiomyopathy complicated by refractory arrhythmias
I
Intervention
Amiodarone
C
Comparator
Verapamil
O
Outcome
Incidence of arrhythmia (ventricular tachycardia, ventricular extrasystoles, atrial fibrillation)surrogate

Amiodarone is highly effective at suppressing refractory ventricular and atrial arrhythmias in patients with hypertrophic cardiomyopathy, whereas verapamil is ineffective.

Abstract

The antiarrhythmic effects of amiodarone and verapamil were compared in 19 patients with hypertrophic cardiomyopathy complicated by refractory arrhythmias. While verapamil did not reduce the incidence of arrhythmia, amiodarone abolished ventricular tachycardia in 10 of 13 patients and significantly reduced the number of ventricular extrasystoles. In addition, sinus rhythm was restored by amiodarone in three of five patients with longstanding atrial fibrillation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

McKenna et al. (1981) studied this question.

synapsesocial.com/papers/6a1468b2a4182367b162cbf8https://doi.org/10.1136/hrt.46.2.173
Ask AI
Helpful
Bookmark
Share
View Full Paper